ardelyx
Ardelyx is seeking an Associate Director of Nonclinical Development to support their drug development programs. The role involves designing and managing nonclinical safety and toxicity studies, collaborating with CROs, and preparing regulatory documents, all within a biopharmaceutical research environment.
Headquarters
Waltham, Massachusetts, United States
Company Size
201-500 employees
Founded
2007
Ardelyx is a biopharmaceutical company that discovers, develops, and commercializes first-in-class medicines for patients with unmet medical needs in gastrointestinal and cardiorenal diseases. The company markets IBSRELA (tenapanor) for irritable bowel syndrome with constipation (IBS-C) and XPHOZAH for chronic kidney disease with hyperphosphatemia, while also pursuing additional pipeline programs including chronic idiopathic constipation. Headquartered in Northern California, Ardelyx is committed to delivering novel-mechanism therapies that improve outcomes for patients with GI and kidney disorders.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for ardelyx.
66% above the average for this role
Associate Director, Nonclinical Safety Evaluation
City Therapeutics
Study Monitor for Nonclinical Safety Studies / Outsourcing Manager
Digital Biology
Director, Nonclinical Research
Madrigal Pharmaceuticals
Associate Director, Toxicology
Latigobio
Associate Director, Study Operations Manager - Nonclinical Toxicology
Centessa Pharmaceuticals
Non-Clinical Development Intern
Olema Oncology